TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
60,868
|
50,559
|
38,697 |
Financial expenses |
879
|
491
|
486 |
Earnings before taxes |
11,989
|
14,031
|
10,243 |
Total assets |
36,201
|
37,954
|
26,854 |
Current assets |
32,143
|
33,281
|
21,455 |
Current liabilities |
22,113
|
22,352
|
14,129 |
Equity capital |
14,087
|
15,315
|
12,474 |
- share capital |
646
|
682
|
646 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
38.9%
|
40.4%
|
46.5% |
Turnover per employee | 1,759 | ||
Profit as a percentage of turnover |
19.7%
|
27.8%
|
26.5% |
Return on assets (ROA) |
35.5%
|
38.3%
|
40.0% |
Current ratio |
145.4%
|
148.9%
|
151.9% |
Return on equity (ROE) |
85.1%
|
91.6%
|
82.1% |
Change turnover |
12,964
|
9,761
|
-3,437 |
Change turnover % |
27%
|
24%
|
-8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.